Amit Rakhit, MD, MBA in

Amit Rakhit, MD, MBA

Evaluator · DISC type scd
Chief Medical Officer at BlueRock Therapeutics
📍 Boston, Massachusetts, United States

Amit is the Chief Medical Officer at BlueRock Therapeutics, an experienced biotech executive who has led teams developing medicines for oncology, neurology, and rare diseases. A physician-scientist, he earned his MD from Tufts University and an MBA from Columbia Business School, previously serving as CEO at Flare Therapeutics.

He is a passionate advocate for LGBTQ+ representation in the life sciences. Amit co-founded KoMocean, a professional networking organization created to support and connect LGBTQ+ leaders across the biopharmaceutical industry, aiming to foster greater inclusion and health equity.

Unique fact: He co-founded KoMocean, a networking group dedicated to supporting and connecting LGBTQ+ leaders across the biopharmaceutical industry.

Read the full overview →
Experience
29 Years
Current Role
Chief Medical Officer
Job Level
Leadership
Location
Boston, Massachusetts, United States
Personality Overview

How Amit shows up

Hard To Convince
Quality Focused
Thorough Evaluator

They focus on the results, but can still be quite procedural and analytical about how to get there They are not very likely to become strong advocates of your product or service They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical

Priorities

Topics Amit cares about

Patient-Centric Development
He consistently emphasizes aligning scientific innovation with patient outcomes, advocating for a development process that is deeply focused on the needs of patients and their caregivers.
Cell Therapy Advancement
As CMO of a cell therapy company, he is focused on developing novel medicines, particularly for conditions like Parkinson's, and follows global progress in manufacturing and regulatory frameworks.
+5 more topics Login to view topics
Career

Work history

6-2024
Chief Medical Officer
BlueRock Therapeutics
7-2022 - 11-2023
Chief Executive Officer
Flare Therapeutics
9-2021 - 6-2022
Director
Asylia Therapeutics, Inc.
9-2021 - 6-2022
Director
Stellanova Therapeutics
8-2021 - 6-2022
Chief Executive Officer
Sporos Bioventures
In the press

Media appearances

Cell & Gene the Podcast – Inside a Dopamine‑Restoring Cell Therapy for Parkinson’s Disease with Amit Rakhit, MD, MBA, Chief Medical Officer, BlueRock Therapeutics. Featured in YouTube
See now
Positive 24‑Month Data of Cell Therapy Bemdaneprocel in Parkinson’s Disease – Interview with Amit Rakhit, MD, MBA, Chief Medical Officer, BlueRock Therapeutics. Featured in NeurologyLive
+1 more appearances Login to view media
Education
2008 - 2010
MBA
Columbia Business School
1991 - 1995
MD
Tufts University School of Medicine
Social presence
in
Behavioral profile

DISC profile (public)

s

Steadiness (S)

Steadiness (S) reflects the degree to which a person is likely to focus on cooperation, support and taking everyone along. Those scoring high tend to be consistent and calm.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Amit. Free, 10 seconds.